use intravenous milrinone chronic symptomatic ischemic heart disease antiischemic effects intravenous milrinone patients coronary artery disease stable angina rest exercise control conditions intravenous injection milrinone min infusion micrograms/kg/min Hemodynamic parameters epinephrine norepinephrine atrial natriuretic factor Control ergometry ischemia exercise intravenous milrinone ischemia unloading effects significant decrease ST segment depression Heart rate rest exercise testing changes mean arterial pressure cardiac output myocardial oxygen consumption exercise different milrinone control phase Intravenous milrinone onset angina duration anginal attacks exercise duration milrinone phase control phase vasodilatation mild secondary increase norepinephrine milrinone phase increase atrial natriuretic factor exercise milrinone result preload reduction Intravenous milrinone beneficial hemodynamic antiischemic effects patients coronary artery disease stable angina reproducible ST segment depression myocardial contractility preload afterload 